GlobeNewswire: GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023
O’Melveny & Myers LLP advised Fall Line Endurance Fund, L.P., a private equity firm uniquely focused on investments in US farmland, active management of farmland, and AgTech startups, as the lead investor in a consortium that has agreed to acquire and take-private Greenlight Biosciences (NASDAQ: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address issues in human health and agriculture, for US$0.30 per share, net of cash. The transaction was announced on May 30 and is expected to close in the third quarter of 2023, subject to customary closing conditions.
Read the full article here.